Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study

Zhiwei Chen, Fang Yang, Zhou Jiang, Longhua Sun, Lin Wu, Zhengxiang Han, Yun Fan, Yanqiu Zhao, Xingya Li, Haipeng Xu, Xiangjiao Meng, Ying Liu, Zhiye Zhang, Hui Luo, Xuelei Ma, Xuezhen Ma, Qin Shi, Zhongmin Zhang, Runxiang Yang, Pingli Wang, Pinhua Pan, Xiaohong Ai, Jie Li, Xingxiang Pu, Zhiwu Wang, Jian Fang, Ming He, Yong He, Shuliang Guo, Juan Li, Hongbiao Wang, Junqiang Zhang, Qian Chu, Xuewen Liu, Shenpeng Ying, Hongcheng Wu, Hongmei Sun, Yinghua Ji, Ming Zhou, Chao Cao, Kejing Tang, Zhengguo Li, Dairong Li, Zhihong Zhang, Jie Li, Jianya Zhou, Hongzhong Yang, Yingying Du, Hui Yang, Jian Shi, Hualin Chen, Amy C. Moore, Shun Lu

Open source

DOI: 10.1080/14796694.2026.2676052
Published: 2026-06-03
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2676052,
  title = {Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study},
  author = {Zhiwei Chen and Fang Yang and Zhou Jiang and Longhua Sun and Lin Wu and Zhengxiang Han and Yun Fan and Yanqiu Zhao and Xingya Li and Haipeng Xu and Xiangjiao Meng and Ying Liu and Zhiye Zhang and Hui Luo and Xuelei Ma and Xuezhen Ma and Qin Shi and Zhongmin Zhang and Runxiang Yang and Pingli Wang and Pinhua Pan and Xiaohong Ai and Jie Li and Xingxiang Pu and Zhiwu Wang and Jian Fang and Ming He and Yong He and Shuliang Guo and Juan Li and Hongbiao Wang and Junqiang Zhang and Qian Chu and Xuewen Liu and Shenpeng Ying and Hongcheng Wu and Hongmei Sun and Yinghua Ji and Ming Zhou and Chao Cao and Kejing Tang and Zhengguo Li and Dairong Li and Zhihong Zhang and Jie Li and Jianya Zhou and Hongzhong Yang and Yingying Du and Hui Yang and Jian Shi and Hualin Chen and Amy C. Moore and Shun Lu},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2676052},
  url = {https://doi.org/10.1080/14796694.2026.2676052}
}

RIS

TY  - JOUR
TI  - Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study
AU  - Zhiwei Chen
AU  - Fang Yang
AU  - Zhou Jiang
AU  - Longhua Sun
AU  - Lin Wu
AU  - Zhengxiang Han
AU  - Yun Fan
AU  - Yanqiu Zhao
AU  - Xingya Li
AU  - Haipeng Xu
AU  - Xiangjiao Meng
AU  - Ying Liu
AU  - Zhiye Zhang
AU  - Hui Luo
AU  - Xuelei Ma
AU  - Xuezhen Ma
AU  - Qin Shi
AU  - Zhongmin Zhang
AU  - Runxiang Yang
AU  - Pingli Wang
AU  - Pinhua Pan
AU  - Xiaohong Ai
AU  - Jie Li
AU  - Xingxiang Pu
AU  - Zhiwu Wang
AU  - Jian Fang
AU  - Ming He
AU  - Yong He
AU  - Shuliang Guo
AU  - Juan Li
AU  - Hongbiao Wang
AU  - Junqiang Zhang
AU  - Qian Chu
AU  - Xuewen Liu
AU  - Shenpeng Ying
AU  - Hongcheng Wu
AU  - Hongmei Sun
AU  - Yinghua Ji
AU  - Ming Zhou
AU  - Chao Cao
AU  - Kejing Tang
AU  - Zhengguo Li
AU  - Dairong Li
AU  - Zhihong Zhang
AU  - Jie Li
AU  - Jianya Zhou
AU  - Hongzhong Yang
AU  - Yingying Du
AU  - Hui Yang
AU  - Jian Shi
AU  - Hualin Chen
AU  - Amy C. Moore
AU  - Shun Lu
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2676052
UR  - https://doi.org/10.1080/14796694.2026.2676052
ER  -

APA

Chen, Z., Yang, F., Jiang, Z., Sun, L., Wu, L., Han, Z., Fan, Y., Zhao, Y., Li, X., Xu, H., Meng, X., Liu, Y., Zhang, Z., Luo, H., Ma, X., Ma, X., Shi, Q., Zhang, Z., Yang, R., Wang, P., Pan, P., Ai, X., Li, J., Pu, X., Wang, Z., Fang, J., He, M., He, Y., Guo, S., Li, J., Wang, H., Zhang, J., Chu, Q., Liu, X., Ying, S., Wu, H., Sun, H., Ji, Y., Zhou, M., Cao, C., Tang, K., Li, Z., Li, D., Zhang, Z., Li, J., Zhou, J., Yang, H., Du, Y., Yang, H., Shi, J., Chen, H., Moore, A. C., & Lu, S. (2026). Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study. Future Oncology. https://doi.org/10.1080/14796694.2026.2676052

Source records

crossref · retrieved 2026-09-26T01:03:20.429Z